ClinicalTrials.Veeva

Menu

SchlaHF-XT-Register. Sleep Disordered Breathing in Heart Failure Register

ResMed logo

ResMed

Status

Completed

Conditions

Heart Failure (HF)

Study type

Observational

Funder types

Industry

Identifiers

NCT02301689
MA120814

Details and patient eligibility

About

The SchlaHF XT Registry is a longitudinal study of patients with heart failure (HF). The study aims to understand the importance of diagnosis and treatment of sleep disordered breathing (SDB) on HF with the following questions:

How often does SDB occur in HF? What forms of SDB occur and how are they treated? How does SDB develop over time? How does the heart failure therapy affect SDB? What is the treatment adherence of patients treated? Does SBD and its treatment affect the survival of heart failure patients?

Enrollment

4,749 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • diagnose chronic heart failure, at least 3 months prior to diagnosis
  • Age 18 years
  • Signed informed consent

Exclusion criteria

  • Existing Positive Airway Pressure (PAP) therapy or long-term oxygen therapy
  • Lack of capacity to consent
  • minors
  • persons who are housed on judicial or administrative order in an institution
  • pregnant and lactating women

Trial design

4,749 participants in 1 patient group

Heart Failure patients

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems